Market Cap 6.52M
Revenue (ttm) 0.00
Net Income (ttm) 30.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 35,600
Avg Vol 115,706
Day's Range N/A - N/A
Shares Out 6.80M
Stochastic %K 42%
Beta -0.05
Analysts Strong Buy
Price Target N/A

Company Profile

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other soli...

Industry: Biotechnology
Sector: Healthcare
Phone: 917-595-2850
Fax: 917-595-2851
Address:
3960 Howard Hughes Parkway, Suite 500, Las Vegas, United States
BHWinehouse
BHWinehouse Oct. 24 at 4:12 PM
$QCLS Yep, that's it! Nothing to do with obtaining exclusive rights to Lightsolver photonics tech saving companies like $MARA 90% on energy or the fact they have MYMD-1 that is ready to enter Ph2 clinical trials which will most likely be sold to $PMCB since they already have $7M invested in it and we the same "ceo". Nothing really to see here....
0 · Reply
Pistol_Pete_P
Pistol_Pete_P Oct. 21 at 5:30 AM
$PMCB scam
0 · Reply
BirchTreeJJ
BirchTreeJJ Oct. 15 at 2:16 PM
$QCLS watching $PMCB ehom I believe will acquire all of WCLS bio assets The cash from the bio assets will fund the new $TAO.X $TAOX crypto strategy @jaltucher wheres the news man. It’s long overdue.
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 14 at 9:39 PM
0 · Reply
Peaceouty
Peaceouty Oct. 14 at 8:55 PM
$SBLX we are owned by a hedge fund, and that explains the harsh price control we’ve seen today. Same with $PMCB
0 · Reply
Peaceouty
Peaceouty Oct. 14 at 8:45 PM
$SBLX Our ceo is also the CEO of $PMCB! Woot woot! Also he’s been the assistant press secretary of the President!
1 · Reply
BHWinehouse
BHWinehouse Oct. 14 at 6:07 PM
1 · Reply
BHWinehouse
BHWinehouse Oct. 14 at 4:07 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 14 at 1:16 PM
$QCLS Also keep in mind, both $QCLS and $PMCB have meetings in the following weeks...
0 · Reply
BurchhausenJj
BurchhausenJj Oct. 14 at 11:56 AM
$PMCB $QCLS $TAOX @BHWinehouse @Dat1099Boi yes all of that is imminent And @jaltucher as a major player This (QCLS) is a fantastic set up. Their bio assets will bring in cash. 💷 💰
0 · Reply
Latest News on PMCB
MyMD Pharmaceuticals Secures Strategic Investments

May 21, 2024, 9:00 AM EDT - 1 year ago

MyMD Pharmaceuticals Secures Strategic Investments


PharmaCyte Biotech Announces Final Results of Tender Offer

Jun 15, 2023, 9:15 AM EDT - 2 years ago

PharmaCyte Biotech Announces Final Results of Tender Offer


PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

Jul 21, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study


Is This A Good Time To Invest In PharmaCyte?

Jan 7, 2022, 2:59 AM EST - 4 years ago

Is This A Good Time To Invest In PharmaCyte?


Why Are PharmaCyte Shares Moving Higher On Thursday?

Sep 16, 2021, 1:51 PM EDT - 4 years ago

Why Are PharmaCyte Shares Moving Higher On Thursday?


BHWinehouse
BHWinehouse Oct. 24 at 4:12 PM
$QCLS Yep, that's it! Nothing to do with obtaining exclusive rights to Lightsolver photonics tech saving companies like $MARA 90% on energy or the fact they have MYMD-1 that is ready to enter Ph2 clinical trials which will most likely be sold to $PMCB since they already have $7M invested in it and we the same "ceo". Nothing really to see here....
0 · Reply
Pistol_Pete_P
Pistol_Pete_P Oct. 21 at 5:30 AM
$PMCB scam
0 · Reply
BirchTreeJJ
BirchTreeJJ Oct. 15 at 2:16 PM
$QCLS watching $PMCB ehom I believe will acquire all of WCLS bio assets The cash from the bio assets will fund the new $TAO.X $TAOX crypto strategy @jaltucher wheres the news man. It’s long overdue.
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 14 at 9:39 PM
0 · Reply
Peaceouty
Peaceouty Oct. 14 at 8:55 PM
$SBLX we are owned by a hedge fund, and that explains the harsh price control we’ve seen today. Same with $PMCB
0 · Reply
Peaceouty
Peaceouty Oct. 14 at 8:45 PM
$SBLX Our ceo is also the CEO of $PMCB! Woot woot! Also he’s been the assistant press secretary of the President!
1 · Reply
BHWinehouse
BHWinehouse Oct. 14 at 6:07 PM
1 · Reply
BHWinehouse
BHWinehouse Oct. 14 at 4:07 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 14 at 1:16 PM
$QCLS Also keep in mind, both $QCLS and $PMCB have meetings in the following weeks...
0 · Reply
BurchhausenJj
BurchhausenJj Oct. 14 at 11:56 AM
$PMCB $QCLS $TAOX @BHWinehouse @Dat1099Boi yes all of that is imminent And @jaltucher as a major player This (QCLS) is a fantastic set up. Their bio assets will bring in cash. 💷 💰
0 · Reply
BHWinehouse
BHWinehouse Oct. 14 at 11:03 AM
$QCLS $PMCB What might be in the works? $QCLS will sell MYMD-1 to $PMCB in the next few weeks. Shortly after is when our first big crypto related announcement takes place. Remember, Joshua Silverman!
2 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 7 at 1:04 PM
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 4 at 11:18 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 3 at 1:15 PM
$QCLS $PMCB MYMD-1 PEER REVIEWED and for sale!! https://news.biobuzz.io/2025/07/16/mymd-pharmaceuticals-announces-publication-of-phase-1-data-for-oral-tnf-alpha-inhibitor-mymd-1-in-peer-reviewed-journal-drug-research/?utm_source=chatgpt.com
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 3 at 12:55 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 2 at 11:09 PM
$QCLS $PMCB Could be closer than we think... MYMD-1 will be sold, it's just a matter of when and for how much. AND oh yeah, the whole Lightsavor thing!
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 1 at 8:28 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 1 at 1:06 PM
$QCLS $PMCB i feel a deal is close
0 · Reply
BHWinehouse
BHWinehouse Sep. 30 at 2:53 PM
$QCLS $PMCB I think JJ is closer to right than wrong on this one: PharmaCyte had approximately $15.5 million in cash and also holds over $30 million of securities as reflected in the Company’s most recent 10K. With the addition of the $7 million in proceeds from this financing, the Company’s balance sheet has been further strengthened, providing significant financial flexibility to support its ongoing business initiatives and strategic growth opportunities.
1 · Reply
Dfastpitchchic5
Dfastpitchchic5 Sep. 29 at 1:35 PM
0 · Reply
TruthTrader
TruthTrader Sep. 26 at 2:20 AM
$ORBS $PMCB $WLDS pmcb held it for years when it was trading 3 dollars. Snails in my back yard saw more action than this stock. The defifinition of dead money. Company issued shares/placement so that management could get paid for years to come. They said they cared about shareholder value but did nothing. $QURE take note here. I dumped at a loss. I will never buy a biotech stock again. Never!
1 · Reply
ChartChartist
ChartChartist Sep. 24 at 4:46 PM
$PMCB looking for a nice one
0 · Reply